id core xt

U.S. Food & Drug Administration News: FDA approves new DNA-based test to determine blood compatibility

SILVER SPRING, MD – The U.S. Food and Drug Administration today approved ID CORE XT, a molecular-based assay used in blood transfusion medicine to help determine blood compatibility.  The assay can be used to determine blood donor and patient non-ABO red blood cell (RBC) types.  ID CORE XT is the second molecular assay approved for … Continue reading U.S. Food & Drug Administration News: FDA approves new DNA-based test to determine blood compatibility